NHWD-870 protects the kidney from ischemia/reperfusion injury by upregulating the PI3K/AKT signaling pathway

Saba Sahib Younis1, Fadhaa Abdul Ameer Ghafil2, Sahar Majeed2

  • 1Al-Sadr Medical City, Al-Najaf Health Directorate, Al Najaf Al-Ashraf, Iraq.

PubMed

Insights

NHWD-870, a Brd4 inhibitor, shows significant nephroprotective effects against renal ischemia-reperfusion injury in rats. It reduces kidney damage by decreasing inflammation and oxidative stress, preserving renal function and tissue integrity.

Area of Science:

  • Nephrology
  • Pharmacology
  • Molecular Biology

Background:

  • Renal ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury.
  • NHWD-870, a Brd4 inhibitor, possesses antioxidant, anti-inflammatory, and anti-apoptotic properties.
  • These properties suggest NHWD-870's potential for mitigating IRI-induced renal damage.

Purpose of the Study:

  • To evaluate the nephroprotective effects of NHWD-870 in a rat model of renal IRI.
  • To investigate the underlying anti-apoptotic, anti-inflammatory, and antioxidant mechanisms of NHWD-870.

Main Methods:

  • Male Wistar Albino rats were subjected to 30 minutes of bilateral renal ischemia and 2 hours of reperfusion.
  • NHWD-870 (3mg/kg) was administered orally 24 hours prior to the IRI procedure.
  • Renal function was assessed by blood urea nitrogen (BUN) and serum creatinine (SCr).
  • Inflammatory marker (IL-1β), apoptotic markers (Bcl-2), oxidative stress marker (PGF-2), and PI3K/AKT pathway were analyzed using ELISA.
  • Renal tissue damage was evaluated through histopathology.

Main Results:

  • NHWD-870 treatment significantly improved renal function, indicated by reduced BUN and SCr levels.
  • Histopathological analysis revealed reduced tubular injury severity in the NHWD-870 group.
  • NHWD-870 administration led to decreased levels of IL-1β and PGF-2, and increased Bcl-2 levels in renal tissue.
  • The PI3K/AKT signaling pathway was significantly upregulated following NHWD-870 treatment.

Conclusions:

  • NHWD-870 demonstrates significant nephroprotective effects against renal IRI in rats.
  • These protective effects are likely mediated by its anti-apoptotic (via Bcl-2), anti-inflammatory (via IL-1β reduction), and antioxidant (via PGF-2 reduction) properties.
  • Upregulation of the PI3K/AKT pathway contributes to the observed renoprotection by NHWD-870.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
26
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
28